난소 절제술을 시행한 쥐와 정상 쥐에서 합성 골 재료의 이식 후 신생 골 생성 비교

Comparison on New Bone Formation Between Ovariectomized Rats and Normal Rats After Graft of Alloplastic bone material

  • 이종원 (고려대학교 임상치의학 연구소) ;
  • 안진수 (고려대학교 임상치의학 연구소) ;
  • 안재석 (고려대학교 임상치의학 연구소) ;
  • 류재준 (고려대학교 임상치의학 연구소)
  • Lee, Jong-Won (Korea University Institute for Clinical Dental Research) ;
  • Ahn, Jin-Su (Korea University Institute for Clinical Dental Research) ;
  • Ahn, Jae-Seok (Korea University Institute for Clinical Dental Research) ;
  • Ryu, Jae-Jun (Korea University Institute for Clinical Dental Research)
  • 발행 : 2008.08.29

초록

연구목적: 난소 절제술을 시행하여 골다공증을 재연한 쥐의 두개 결함부에 골 이식시 정상 쥐와 어떠한 골 재생 능력 차이를 보이는지 비교하고자 한다. 연구재료 및 방법: 20마리의 쥐를 2 그룹으로 각 10마리씩 나눈다. 그 중 10마리만 난소 절제술을 시행하고 7주 후 20마리 모두 두개골에 8 mm 직경의 임계 크기의 결함을 형성한 후 $OSTEON^{TM}$을 이식한다. 그 후 4주 후 모두 희생하여 조직학적 조각을 형성하여 방사선학적 및 조직형태학적 분석을 시행한다. 결과: Ovariectomy & $OSTEON^{TM}$군과 Non-Ovariectomy & $OSTEON^{TM}$군과의 신생골 형성 넓이의 효과 검증 결과, Ovariectomy & $OSTEON^{TM}$군은 평균 넓이는 19660.93 ${\pm}$ 17207.68 ${\mu}m$으로 Non-Ovariectomy & $OSTEON^{TM}$군의 69793.57 ${\pm}$ 33227.17 ${\mu}m$에 비해 적어진 것으로 나타났으며, 이러한 차이는 통계적으로도 유의한 것으로 나타났다 (t = -4.237, P < .01). 따라서 Ovariectomy & $OSTEON^{TM}$군의 new bone formation 넓이가 Non-Ovariectomy & $OSTEON^{TM}$군에 비해 작아진 것을 알 수 있다. Ovariectomy & $OSTEON^{TM}$ 군과 Non-Ovariectomy & $OSTEON^{TM}$ 군과의 알칼리 포스파타아제의 효과 검증 결과, Ovariectomy & $OSTEON^{TM}$군은 ALP는 평균 163.90 ${\pm}$ 61.44 IU/L으로 Non-Ovariectomy & $OSTEON^{TM}$군의 58.40 ${\pm}$ 18.30 IU/L에 비해 크게 높아진 것으로 나타났으며, 이러한 차이는 통계적으로도 유의한 것으로 나타났다 (t = 5.204, P < .001). 따라서 Ovariectomy & $OSTEON^{TM}$군의 ALP 수치가 Non-Ovariectomy & $OSTEON^{TM}$군 ALP 수치보다 높아진 것을 알 수 있다. 결론: 본 실험을 통해 골다공증이 유발되면 골 재생능력이 감소한다는 것을 결론지을 수 있다.

Purpose of study: To compare on bone formation between ovariectomized rats and normal rats after graft of alloplastic bone material. Material and methods: Twenty female rats were used in this study. They were divided into two groups by each ten rats. One group was ovariectomized and grafted alloplastic bone material. Other group was non-ovariectomized and grafted alloplastic bone material. After a healing time of 4 weeks, the animals were sacrificed and decalcified preparations were routinely processed for histologic evaluations. Results: Ovariectomy group was significantly lesser bone formation compared with non-ovariectomy group. Conclusions: Ovariectomy acts as a negative factor in new bone formation.

키워드

참고문헌

  1. Kruger GO. Textbook of Oral and Maxillofacial Surgery. St Louis, MO, Mosby, 1984
  2. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41 https://doi.org/10.1002/jbmr.5650090802
  3. Eriksen EF, Colvard DS, Berg NJ. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84-6 https://doi.org/10.1126/science.3388021
  4. Lindberg MK, Erlandsson M, Alatalo SL, Windahl S, Andersson G, Halleen JM, Carlsten H, Gustafsson JA, Ohlsson C. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin / receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. J Endocrinol 2001;171:425-33 https://doi.org/10.1677/joe.0.1710425
  5. Pacifici R. Is there a causal role for IL-1 in postmenopausal bone loss- Calcif Tissue Int 1992;50:295-9 https://doi.org/10.1007/BF00301625
  6. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-14 https://doi.org/10.1126/science.289.5484.1508
  7. Burg MA, Fraser K, Gui S, Grant K, Kosch SG, Nierenberg B, Oyama O, Pomm H, Sibille K, Spruill T, Swartz V. Florida Behavioral Health Research Consortium. Treatment of menopausal symptoms in family medicine settings following the Women's Health Initiative findings. J Am Board Fam Med 2006;19:122-31 https://doi.org/10.3122/jabfm.19.2.122
  8. Miller SC, Hunziker J, Mechman M, Wronsky TJ. Intermittent parathyroid hormone administration stimulus bone formation in the mandibles of aged ovariectomized rats. J Dent Res 1997;76:1471-6 https://doi.org/10.1177/00220345970760080901
  9. Von Wowern N, Klausen B, Kollerup G. Osteoporosis: a risk factor in periodontal disease. J Periodontol 1994;65:1134-8 https://doi.org/10.1902/jop.1994.65.12.1134
  10. Kribbs PJ, Chesnut CH 3rd, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in an osteoporotic population. J Prosthet Dent 1989;62:703-7 https://doi.org/10.1016/0022-3913(89)90596-9
  11. Kribbs PJ. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dent 1990;63:218-22 https://doi.org/10.1016/0022-3913(90)90108-O
  12. von Wowern N, Klausen B, Kollerup G. Osteoporosis: a risk factor in periodontal disease. J Periodontol 1994;65:1134-8 https://doi.org/10.1902/jop.1994.65.12.1134
  13. Wactawski-Wende J, Grossi SG, Trevisan M, Genco RJ, Tezal M, Dunford RG, Ho AW, Hausmann E, Hreshchyshyn MM. The role of osteopenia in oral bone loss and periodontal disease. J Periodontol 1996;67:1076- 84 https://doi.org/10.1902/jop.1996.67.10s.1076
  14. Takagi K, Urist MR. The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects. Ann Surg 1982;196:100-9 https://doi.org/10.1097/00000658-198207000-00020
  15. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986;205:299-308
  16. Kim SY, Kim SG, Lim SC, Bae CS. Effects on Bone Formation in Ovariectomized Rats After Implantation of Tooth Ash and Plaster of Paris Mixture. J Oral Maxillofac Surg 2004;62:852-7 https://doi.org/10.1016/j.joms.2003.12.023
  17. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 2003;111:1221-30 https://doi.org/10.1172/JCI200317215
  18. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Sl􀝚rdahl K, Tamburstuen MV, Reseland JE, Syversen U. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 2006;98:139-51 https://doi.org/10.1002/jcb.20734
  19. Gilles JA, Carnes DL, Dallas MR, Holt SC, Bonewald LF. Oral bone loss is increased in ovariectomized rats. J Endod 1997;23:419-25 https://doi.org/10.1016/S0099-2399(97)80294-4
  20. Loza JC, Carpio LC, Dziak R. Osteoporosis and its relationship to oral bone loss. Curr Opin Periodontol 1996;3:27-33
  21. Hara T, Sato T, Oka M, Mori S, Shirai H. Effects of ovariectomy and/or dietary calcium deficiency on bone dynamics in the rat hard palate, mandible and proximal tibia. Arch Oral Biol 2001;46:443-51 https://doi.org/10.1016/S0003-9969(00)00135-7
  22. Cao T, Shirota T, Yamazaki M, Ohno K, Michi KI. Bone mineral density in mandibles of ovariectomized rabbits. Clin Oral Implants Res 2001;12:604-8 https://doi.org/10.1034/j.1600-0501.2001.120608.x
  23. Tanaka S, Shimizu M, Debari K, Furuya R, Kawawa T, Sasaki T. Acute effects of ovariectomy on wound healing of alveolar bone after maxillary molar extraction in aged rats. Anat Rec 2001;262:203-12 https://doi.org/10.1002/1097-0185(20010201)262:2<203::AID-AR1030>3.0.CO;2-#
  24. Bae CS. Osteoporotic changes after ovariectomy in rats. Kor J Vent Ciln Med 2000;17:212-7
  25. Duarte PM, de Assis DR, Casati MZ, Sallum AW, Sallum EA, Nociti FH Jr. Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats. J Periodontol 2004;75:1196-202 https://doi.org/10.1902/jop.2004.75.9.1196
  26. Nagareddy PR, Lakshmana M. Withania somnifera improves bone calcification in calcium-deficient ovariectomized rats. J Pharm Pharmacol 2006;58:513-9 https://doi.org/10.1211/jpp.58.4.0011
  27. Marx RE, Carlson ER. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Pathol Oral Radiol Endod 1998;85:638-46 https://doi.org/10.1016/S1079-2104(98)90029-4
  28. Kim SG, Kim WK, Park JC, Kim HJ. A comparative study of osseointegration of Avana Implants in a demineralized freeze-dried bone alone or with platelet-rich plasma. J Oral Maxillofac Surg 2002;60:1018-25 https://doi.org/10.1053/joms.2002.34413
  29. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 2002;37:300-6 https://doi.org/10.1034/j.1600-0765.2002.01001.x
  30. J. Lan, Z.F. Wang, B. Shi, H.B. Xia and X.R. Cheng. The influence of recombinant human BMP-2 on bone implant osseointegration: biomechanical testing and histomorphometric analysis. Int J Oral Maxillofac Surg 2007;36:345-9 https://doi.org/10.1016/j.ijom.2006.10.019
  31. Inoda H, Yamamoto G, Hattori T. rh-BMP2-induced ectopic bone for grafting critical size defects: a preliminary histological evaluation in rat calvariae. Int J Oral Maxillofac Surg 2007;36:39-44 https://doi.org/10.1016/j.ijom.2006.07.011
  32. Matsumoto A, Yamaji K, Kawanami M, Kato H. Effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 ombined with fibrous collagen membranes at subperiosteal sites. J Periodontal Res 2001;36:175-82 https://doi.org/10.1034/j.1600-0765.2001.360306.x